Francesco Amati

1.5k total citations
52 papers, 809 citations indexed

About

Francesco Amati is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Infectious Diseases. According to data from OpenAlex, Francesco Amati has authored 52 papers receiving a total of 809 indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Pulmonary and Respiratory Medicine, 15 papers in Epidemiology and 8 papers in Infectious Diseases. Recurrent topics in Francesco Amati's work include Cystic Fibrosis Research Advances (23 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (10 papers) and Neonatal Respiratory Health Research (9 papers). Francesco Amati is often cited by papers focused on Cystic Fibrosis Research Advances (23 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (10 papers) and Neonatal Respiratory Health Research (9 papers). Francesco Amati collaborates with scholars based in Italy, United States and United Kingdom. Francesco Amati's co-authors include Stefano Aliberti, Francesco Blasi, Andrea Gramegna, Giovanni Sotgiu, Marcos I. Restrepo, Charles S. Dela Cruz, Paolo Tarsia, Anna Stainer, Edoardo Simonetta and Martina Contarini and has published in prestigious journals such as The Lancet, American Journal of Respiratory and Critical Care Medicine and International Journal of Molecular Sciences.

In The Last Decade

Francesco Amati

50 papers receiving 799 citations

Peers

Francesco Amati
Hyun Jung Kim South Korea
Myung Goo Lee South Korea
Lydia Finney United Kingdom
Mikael Gencay Switzerland
Myung Jae Park South Korea
Yee Hyung Kim South Korea
Hyun Jung Kim South Korea
Francesco Amati
Citations per year, relative to Francesco Amati Francesco Amati (= 1×) peers Hyun Jung Kim

Countries citing papers authored by Francesco Amati

Since Specialization
Citations

This map shows the geographic impact of Francesco Amati's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesco Amati with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesco Amati more than expected).

Fields of papers citing papers by Francesco Amati

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francesco Amati. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesco Amati. The network helps show where Francesco Amati may publish in the future.

Co-authorship network of co-authors of Francesco Amati

This figure shows the co-authorship network connecting the top 25 collaborators of Francesco Amati. A scholar is included among the top collaborators of Francesco Amati based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francesco Amati. Francesco Amati is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Khijmatgar, Shahnawaz, Massimo Del Fabbro, Cinzia Maspero, et al.. (2025). Procalcitonin and C-reactive protein as alternative salivary biomarkers in infection and inflammatory diseases detection and patient care: A scoping review. Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano). 7. 111–123. 1 indexed citations
2.
Simonetta, Edoardo, Anna Stainer, Francesco Amati, et al.. (2025). Bronchiectasis and sinonasal diseases: a narrative review. ERJ Open Research. 11(5). 1087–2024.
3.
Stainer, Anna, Dean L. Kellogg, Anoop M. Nambiar, et al.. (2024). Vasoactive drugs for the treatment of pulmonary hypertension associated with interstitial lung diseases: a systematic review. BMJ Open Respiratory Research. 11(1). e002161–e002161. 1 indexed citations
4.
Amati, Francesco, Anna Stainer, Maria De Santis, et al.. (2024). First Report of the Prevalence at Baseline and after 1-Year Follow-Up of Treatable Traits in Interstitial Lung Diseases. Biomedicines. 12(5). 1047–1047. 2 indexed citations
5.
Gramegna, Andrea, Gianfranco Alicandro, Mariangela Retucci, et al.. (2024). Relationship Between Lung Volumes and Heterogeneity in the Response to Elexacaftor/Tezacaftor/Ivacaftor in Patients With Cystic Fibrosis and Advanced Lung Disease. CHEST Journal. 166(3). 433–441. 2 indexed citations
6.
Amati, Francesco, Anna Stainer, Andrea Gramegna, et al.. (2023). Identify Drug-Resistant Pathogens in Patients with Community-Acquired Pneumonia. Advances in respiratory medicine. 91(3). 224–238. 8 indexed citations
7.
Gramegna, Andrea, Fabio Majo, Gianfranco Alicandro, et al.. (2023). Heterogeneity of weight gain after initiation of Elexacaftor/Tezacaftor/Ivacaftor in people with cystic fibrosis. Respiratory Research. 24(1). 164–164. 14 indexed citations
8.
Gramegna, Andrea, Jayanth Kumar Narayana, Francesco Amati, et al.. (2023). Microbial Inflammatory Networks in Bronchiectasis Exacerbators With Pseudomonas aeruginosa. CHEST Journal. 164(1). 65–68. 8 indexed citations
9.
Stainer, Anna, Maria De Santis, Francesco Amati, et al.. (2023). Unmet needs and perspectives in rheumatoid arthritis-associated interstitial lung disease: A critical review. Frontiers in Medicine. 10. 1129939–1129939. 14 indexed citations
10.
Narayana, Jayanth Kumar, Stefano Aliberti, Micheál Mac Aogáin, et al.. (2022). Microbial Dysregulation of the Gut-Lung Axis in Bronchiectasis. American Journal of Respiratory and Critical Care Medicine. 207(7). 908–920. 64 indexed citations
11.
Gramegna, Andrea, Andrea Lombardi, Nicola Ivan Lorè, et al.. (2022). Innate and Adaptive Lymphocytes in Non-Tuberculous Mycobacteria Lung Disease: A Review. Frontiers in Immunology. 13. 927049–927049. 14 indexed citations
12.
Amati, Francesco, Giovanni Sotgiu, Andrea Gramegna, et al.. (2022). Nontuberculous mycobacteria infection and pulmonary disease in bronchiectasis. ERJ Open Research. 8(4). 60–2022. 11 indexed citations
13.
Pascual-Guàrdia, Sergi, Francesco Amati, Judith Marín‐Corral, et al.. (2022). Bacterial Patterns and Empiric Antibiotic Use in COPD Patients With Community-Acquired Pneumonia. Archivos de Bronconeumología. 59(2). 90–100. 8 indexed citations
14.
Aliberti, Stefano, Charles S. Dela Cruz, Francesco Amati, Giovanni Sotgiu, & Marcos I. Restrepo. (2021). Community-acquired pneumonia. The Lancet. 398(10303). 906–919. 128 indexed citations
15.
Aliberti, Stefano, Francesco Amati, Andrea Gramegna, et al.. (2021). Comparison of different sets of immunological tests to identify treatable immunodeficiencies in adult bronchiectasis patients. ERJ Open Research. 8(1). 388–2021. 6 indexed citations
16.
Aliberti, Stefano, Giovanni Sotgiu, Andrea Gramegna, et al.. (2021). Thrombocytosis during Stable State Predicts Mortality in Bronchiectasis. Annals of the American Thoracic Society. 18(8). 1316–1325. 8 indexed citations
17.
Santus, Pierachille, et al.. (2021). Switching to nebulised short acting bronchodilators does not increase the risk of arrhythmia in patients hospitalized with a COPD exacerbation. Pharmacological Research. 173. 105915–105915. 3 indexed citations
18.
Aliberti, Stefano, Francesco Amati, Marta Di Pasquale, et al.. (2020). COVID-19 multidisciplinary high dependency unit: the Milan model. Respiratory Research. 21(1). 260–260. 17 indexed citations
19.
Amati, Francesco, Edoardo Simonetta, Andrea Gramegna, et al.. (2019). The biology of pulmonary exacerbations in bronchiectasis. European Respiratory Review. 28(154). 190055–190055. 56 indexed citations
20.
Gramegna, Andrea, Francesco Amati, Leonardo Terranova, et al.. (2017). Neutrophil elastase in bronchiectasis. Respiratory Research. 18(1). 211–211. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026